Crispr Medicine News

02/03/2024

**The First CRISPR Medicine Conference in April 2024**
Close to Be Fully Booked | Few workshop seats available | +50 Speakers | +300 delegates | +25 sponsors

Fourwaves - The CRISPR Medicine Conference

02/01/2024

https://event.fourwaves.com/crisprmed24/pages
The First CRISPR Medicine Conference in Copenhagen, April 23-25 2024
Remember Early Bird deadline January 12th

29/12/2023

Clinical Highlights From the Gene-Editing Field in 2023

https://crisprmedicinenews.com/news/clinical-highlights-from-the-gene-editing-field-in-2023/

09/10/2023

Editing Stem Cells In Vivo: A Major Stride in Gene Therapy for Blood Disorders

By decorating lipid nanoparticles with a cell-specific surface marker, researchers from the University of Pennsylvania were able to edit haematopoietic stem cells in vivo, offering a key alternative to ex vivo cell therapies.

05/10/2023

**WEBINAR Oct 18th**
CATCHing Tumour DNA: Using CRISPR to Detect Cancer in the Gut

Wednesday October 18, 2023 | 3:00 pm–4:00 pm CEST / 9:00 am–10:00 am EDT

Speaker: Dan Worthley M.D., Ph.D., Gastroenterologist at Colonoscopy Clinic, Australia

CATCHing Tumour DNA: Using CRISPR to Detect Cancer in the Gut | Wednesday October 18, 2023 | 3:00 pm–4:00 pm CEST / 9:00 am–10:00 am EDT

04/10/2023

𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐓𝐫𝐢𝐚𝐥 𝐑𝐨𝐮𝐧𝐝𝐮𝐩: 𝐁𝐚𝐬𝐞 𝐄𝐝𝐢𝐭𝐨𝐫𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐂𝐥𝐢𝐧𝐢𝐜 🏥

In this clinical trial roundup, we present an overview of the ongoing clinical trials involving base-editing therapeutic candidates. This article includes trials sponsored by Beam Therapeutics, Verve Therapeutics, and Great Ormond Street Hospital for Children NHS Foundation Trust (UK).

20/09/2023

https://event.fourwaves.com/crisprmed24/pages
The First CRISPR Medicine Conference is officially launched!! 🚀

**The Gateway to Future Gene and Cell Therapies**

We are extremely excited to go live with the first CRISPR Medicine Conference, taking place in Copenhagen, Denmark, April 2024

Meet the European CRISPR Medicine community from the academic and industry segments, join the sessions, the workshops and the network meetings to get the latest updates, and find your next collaboration at the social events.

▶ 20 confirmed speakers
▶ In-person and virtual events
▶ Workshops (limited seats), network meetings and social events
▶ Early bird registration until 1st December 2023
▶ Abstract submission deadline 5th January 2024
▶ Expect 500 delegates, 50 speakers and 25 sponsors...

Scientific Committee​:
· Alessia Cavazza, Ass. Prof., Group Leader, University College London Greater Ormond Street Institute of Child Health, England
· Anna Cereseto, Prof. and Vice-Director, Centre for Integrative Biology (CIBIO), University of Trento, Italy
· Marcello Maresca, Senior Director, Genome Engineering Team, AstraZeneca, Sweden
· Toni Cathomen, Prof. and Director of the Institute for Transfusion Medicine and Gene Therapy, University of Freiburg, Germany
· Karen O'Hanlon Cohrt, PhD, Chief Editor, CRISPR Medicine News

Sponsors:
Ampliqon A/S, Benchling, BioSpring GmbH, Countagen, Samplix, SciLifeLab, Synthego Corporation, Vivlion GmbH, ZeClinics...

We are looking forward to meeting you in Copenhagen in April 2024.

The CMN Team

Fourwaves - The CRISPR Medicine Conference

19/08/2023

The First CRISPR Medicine Conference Copenhagen, Denmark April 23-25 2024

Meet the leading scientists from the CRISPR Medicine/Genomic Medicine field. Latest news tools, delivery systems, safety, diseases and trials...( )

15/06/2023

https://crisprmedicinenews.com/

The First CRISPR Medicine Conference in Copenhagen April 2024

Meet the European CRISPR Medicine/Genomic Medicine community in Copenhagen, Denmark 2024

Focus: Tools, Delivery, Safety/Off-target, Diseases, Pre-clinical/clinical

Segments: University, Hospital, Biotech, Pharma, CRO

+500 delegates, +25 speakers, Poster session, Workshops, Network meetings...

Official website live early Q3 2023

At CRISPR Medicine News we focus on topics related to genetic medicine, gene therapy and genome editing using CRISPR for treatment of human diseases. We strive to bring the best and most interesting interviews and news on everything related to this exciting and rapidly emerging field.

14/06/2023

https://crisprmedicinenews.com/news/crispr-trial-update-editas-reports-positive-initial-data-from-sickle-cell-disease-and-beta-thalasse/

CRISPR Trial Update: Editas Reports Positive Initial Data From Sickle Cell Disease and Beta-Thalassemia Trials
Editas Medicine recently announced positive initial safety and efficacy data for its CRISPR-edited cell therapy EDIT-301. The data was obtained from the first four sickle cell disease patients and the first beta-thalassemia patient treated in the ongoing RUBY and EdiTHAL clinical trials.

Editas Medicine recently announced positive initial safety and efficacy data for its CRISPR-edited cell therapy EDIT-301. The data was obtained from the first four sickle cell disease patients and the first beta-thalassemia patient treated in the ongoing RUBY and EdiTHAL clinical trials.

28/03/2023

https://crisprmedicinenews.com/news/appetite-for-destruction-the-indiscriminate-nuclease-activity-of-cas12a2/

Researchers from Utah State University and Germany’s Helmholtz Institute for RNA-based Infection Research demonstrate that upon recognition of an RNA target, Cas12a2 cleaves all the other nucleic acids present, destroying the bacterial cell and preventing bacteriophage from replicating.

24/01/2023

A Gene-Edited Cell Therapy for an Incurable Disease

Professor Stephanie Cherqui of University of California San Diego’s School of Medicine recently received a prestigious grant from the Californian Institute of Regenerative Medicine, which will allow her and her team to bring her novel CRISPR therapy for the fatal neurodegenerative disease Friedrei...

12/01/2023

https://crisprmedicinenews.com/news/gene-editing-clinical-trials-highlights-of-2022/

Gene-Editing Clinical Trials: Highlights of 2022

To mark the start of 2023, we look back on some of the key advances in gene-editing clinical trials from 2022.

08/01/2023

Many news from the CRISPR Medicine field first week of 2023

Some of the best links we picked up around the internet

28/11/2022

https://crisprmedicinenews.com/news/harmonising-the-community-of-genome-editing-with-the-first-set-of-standardised-terms-interview-sam/

Samantha Maragh from the US National Institute of Standards and Technology (NIST) discusses the significance of the recent publication of a set of standardised genome-editing terms in a community-based project spearheaded by NIST.

18/11/2022

"Last week, PACT Pharma shared results from the first clinical trial using CRISPR to direct patients’ immune cells to treat solid tumours. The findings, which were published in an unedited manuscript in Nature, provide early proof-of-concept that patient immune cells can be reprogrammed to attack their own cancer"

Last week, PACT Pharma shared results from the first clinical trial using CRISPR to direct patients’ immune cells to treat solid tumours. The findings, which were published in an unedited manuscript in Nature, provide early proof-of-concept that patient immune cells can be reprogrammed to attack t...

14/10/2022

Your Weekly CRISPR Medicine News

https://crisprmedicinenews.com/news/cmn-weekly-14-october-2022-your-weekly-crispr-medicine-news/

30/09/2022

https://crisprmedicinenews.com/news/cmn-weekly-30-september-2022-your-weekly-crispr-medicine-news/

Some of the best links we picked up around the internet

26/09/2022

https://crisprmedicinenews.com/news/new-hope-for-cancer-immunotherapies-crispr-knockout-of-a-chromatin-remodelling-factor-reverses-t-ce/

Researchers in the U.S. recently shed much needed light on the molecular mechanisms underpinning T cell exhaustion, revealing an epigenetic regulator as a key target for the improvement of T cell therapies for cancer.

17/09/2022

https://crisprmedicinenews.com/news/cmn-weekly-16-september-2022-your-weekly-crispr-medicine-news/

Some of the best links we picked up around the internet

05/09/2022

https://crisprmedicinenews.com/news/crispr-gene-silencing-offers-hope-for-ultra-rare-muscular-dystrophies/

Patients with collagen VI-related disorders experience progressive and debilitating disease. New research findings from Spain’s Institut de Recerca Sant Joan de Déu (IRSJD) provides new hope for these diseases, demonstrating the power of CRISPR-Cas9 to silence a dominant negative mutation in pati...

31/08/2022

https://crisprmedicinenews.com/news/clinical-update-graphite-bio-doses-first-patient-with-potential-crispr-cure-for-sickle-cell-disease/

Graphite Bio reports dosing the first patient with its lead CRISPR therapy candidate nula-cel in Phase 1/2 trial for sickle cell disease.

28/08/2022

https://crisprmedicinenews.com/news/cmn-weekly-26-august-2022-your-weekly-crispr-medicine-news/

Some of the best links we picked up around the internet

19/08/2022

https://crisprmedicinenews.com/news/cmn-weekly-19-august-2022-your-weekly-crispr-medicine-news/

Some of the best links we picked up around the internet

17/08/2022

https://crisprmedicinenews.com/news/first-patient-is-dosed-with-base-editor-to-treat-familial-hypercholesterolemia-interview-sekar-kat/

Verve Therapeutics recently announced the first human dosing with VERVE-101, an investigational base-editing therapy that is designed to treat heterozygous familial hypercholesterolemia. VERVE-101 is the first in vivo base-editing therapy to reach human clinical trials. Here, Verve Therapeutics’ C...

14/08/2022

https://crisprmedicinenews.com/news/cmn-weekly-14-august-2022-your-weekly-crispr-medicine-news/

Some of the best links we picked up around the internet

05/08/2022

https://crisprmedicinenews.com/news/cmn-weekly-5-august-2022-your-weekly-crispr-medicine-news/

Some of the best links we picked up around the internet

31/07/2022

https://crisprmedicinenews.com/news/cmn-weekly-31-july-2022-your-weekly-crispr-medicine-news/

Some of the best links we picked up around the internet

22/07/2022

Weekly CRISPR Medicine News
https://crisprmedicinenews.com/news/cmn-weekly-22-july-2022-your-weekly-crispr-medicine-news/

Some of the best links we picked up around the internet

21/07/2022

Genomic Medicine Candidates for Sickle Cell Disease
https://crisprmedicinenews.com/news/disease-roundup-genomic-medicine-candidates-for-sickle-cell-disease/

This up-to-date roundup presents the 7 clinical-stage gene-editing approaches to sickle cell disease, which affects millions of people worldwide and is the most common inherited blood disorder in the United States. Current clinical-stage approaches to treating this disease include CRISPR-Cas9, CRISP...